Aurobindo sets eyes on API CRAMS biz
Aurobindo has announced long term plans to steer away from its generics making business in a bid to focus on long term API manufacturing partnerships.
Archives for August 7, 2012
UCF team accidentally discovers "game changing" nanoparticle mass production method
Scientists at UCF (University of Central Florida) believe they have found a simpler and more efficient way to mass produce the structured nanoparticles used for drug delivery and production.
Halo seeks renewal as controlled substance producer; buys Teva plant
US CMO Halo Pharma has asked the Drug Enforcement Administration (DEA) to renew its registration as a manufacturer of controlled substances.
Pharmexcil: wants input on tax laws; and says Sri Lanka is an opportunity for Pharma
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) wants members to suggest changes to tax laws governing pharmaceutical exports ahead of India’s next budget.
Access to patient population more important than price for Phase I outsourcing, says ISR
Access to patient populations is a bigger deciding factor than low cost when selecting a Phase I service provider, according to ISR’s new quality benchmarking report.
Almac doubles refrigerator capacity for trial suppliers seeking biologics business
Almac has doubled refrigerator capacity at its site in Craigavon, Northern Ireland citing demand from its roster of biologics producing clients.